mRNA |
tandutinib |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
BMS-345541 |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
nintedanib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.4 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.4 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.4 |